Literature DB >> 2054265

The effect of magnesium hydroxide on the oral absorption of ibuprofen, ketoprofen and diclofenac.

P J Neuvonen1.   

Abstract

1. The effect of magnesium hydroxide on the oral absorption of ibuprofen, ketoprofen and diclofenac was investigated in two randomized cross-over studies, both consisting of two phases. 2. Single doses of magnesium hydroxide (850 mg) or of water (150 ml) only were given to six healthy volunteers immediately after the ingestion of ibuprofen (400 mg, Study 1), ketoprofen (50 mg, Study 2) or diclofenac (50 mg, Study 2). Plasma drug concentrations were measured up to 24 h. 3. Magnesium hydroxide increased the area under the plasma ibuprofen concentration-time curve between 0 and 1 h by 65% (P less than 0.05) and the peak concentration of ibuprofen in plasma by 31% (P less than 0.01). The time to peak was shortened by about 0.5 h. The extent of bioavailability of ibuprofen was not increased by magnesium hydroxide. 4. Neither the rate nor the extent of absorption of ketoprofen or diclofenac was changed significantly by magnesium hydroxide. 5. When rapid onset of the analgesic effect of ibuprofen is required, concomitant ingestion of an antacid, which contains magnesium hydroxide without aluminium, is recommended.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2054265      PMCID: PMC1368350          DOI: 10.1111/j.1365-2125.1991.tb05527.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

1.  Effect of antacid suspension on the pharmacokinetics of ibuprofen.

Authors:  N Gontarz; R E Small; T J Comstock; D J Stalker; S M Johnson; H E Willis
Journal:  Clin Pharm       Date:  1987-05

Review 2.  Drug-antacid interactions: assessment of clinical importance.

Authors:  P F D'Arcy; J C McElnay
Journal:  Drug Intell Clin Pharm       Date:  1987 Jul-Aug

3.  High-performance liquid chromatographic determination of ibuprofen and its major metabolites in biological fluids.

Authors:  G F Lockwood; J G Wagner
Journal:  J Chromatogr       Date:  1982-11-12

4.  Bioavailability of three commercial preparations of ibuprofen 600 mg.

Authors:  E Källström; M Heikinheimo; H Quiding
Journal:  J Int Med Res       Date:  1988 Jan-Feb       Impact factor: 1.671

5.  Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids.

Authors:  P J Neuvonen; K T Kivistö
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  A high-pressure liquid chromatographic methods for the assay of ketoprofen in plasma and urine, and its application to determining the urinary excretion of free and conjugated ketoprofen following oral administrations of Orudis to man.

Authors:  C M Kaye; M G Sankey; J E Holt
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

7.  The correlation between blood levels of ibuprofen and clinical analgesic response.

Authors:  E M Laska; A Sunshine; I Marrero; N Olson; C Siegel; N McCormick
Journal:  Clin Pharmacol Ther       Date:  1986-07       Impact factor: 6.875

  7 in total
  10 in total

1.  The use of natural health products by paediatric patients in respite care.

Authors:  Audrey Beringer; Régis Vaillancourt; Gilda Villarreal; Christina Vadeboncoeur
Journal:  Paediatr Child Health       Date:  2015 Jan-Feb       Impact factor: 2.253

Review 2.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

Review 3.  Clinically significant drug interactions with antacids: an update.

Authors:  Ryuichi Ogawa; Hirotoshi Echizen
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

5.  Effect of magnesium hydroxide on the absorption and efficacy of tolbutamide and chlorpropamide.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  Lack of effect of omeprazole or of an aluminium hydroxide/magnesium hydroxide antacid on the pharmacokinetics of lumiracoxib.

Authors:  Graham Scott; Christine Vinluan Reynolds; Slavica Milosavljev; Wayne Langholff; Magdy Shenouda; Christiane Rordorf
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 7.  Drug interactions with antacids. Mechanisms and clinical significance.

Authors:  D C Sadowski
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

Review 8.  Enhancement of drug absorption by antacids. An unrecognised drug interaction.

Authors:  P J Neuvonen; K T Kivistö
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

9.  The pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans. Effect of cimetidine.

Authors:  T B Vree; M Van Den Biggelaar-Martea; C P Verwey-Van Wissen; M L Vree; P J Guelen
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335

Review 10.  Influence of Food on Paediatric Gastrointestinal Drug Absorption Following Oral Administration: A Review.

Authors:  Hannah K Batchelor
Journal:  Children (Basel)       Date:  2015-06-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.